Coagulation factor X level – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 11:25:20 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Coagulation factor X level – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 VMX-C001 in Patients Taking Factor Xa Inhibitors Who Need Urgent Surgery or an Invasive Procedure With High Bleeding Risk https://clinicaltrials.eu/trial/vmx-c001-in-patients-taking-factor-xa-inhibitors-who-need-urgent-surgery-or-an-invasive-procedure-with-high-bleeding-risk/ Fri, 29 May 2026 04:02:47 +0000 https://clinicaltrials.eu/trial/vmx-c001-in-patients-taking-factor-xa-inhibitors-who-need-urgent-surgery-or-an-invasive-procedure-with-high-bleeding-risk/ This clinical trial is studying people who are taking a Factor Xa inhibitor, a blood thinner that helps prevent harmful blood clots, and who need urgent surgery or another invasive procedure, meaning a medical procedure that enters the body and has a high risk of bleeding. The study is testing VMX-C001, an intravenous medicine given through a vein, compared with usual medical care. The purpose of the study is to see how well VMX-C001 helps control bleeding during the urgent procedure.

People in the study will receive either VMX-C001 or the usual care used for this situation. Some participants may also receive heparin, another blood-thinning medicine, if planned by the treating team. The study is designed to compare the two approaches during the procedure and shortly afterward, without changing the urgent care needed for the surgery or procedure.

]]>